Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Melanoma × Hematologic Tests × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 3 Colorectal Neoplasms 3 Breast Neoplasms 3 Neoplasms 2 Neoplasm Metastasis 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Colonic Neoplasms 2 Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer 1 Testicular Germ Cell Tumor 1 Stroke 1 Stomach Neoplasms 1 Prostate Cancer Metastatic 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Obesity 1 Non-alcoholic Fatty Liver Disease 1 Neoplastic Cells, Circulating 1 Motor Activity 1 Metabolic Syndrome 1 Memory Disorders 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Liver Cirrhosis 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Hodgkin Disease 1 Heart Diseases 1 HPV Positive Oropharyngeal Squamous Cell Carcinoma 1 Cognitive Dysfunction 1

Interventions

Ipilimumab 100 pembrolizumab 84 aldesleukin 81 Nivolumab 79 Interleukin-2 50 Cyclophosphamide 50 Dacarbazine 47 Vemurafenib 35 trametinib 34 incomplete Freund's adjuvant 33 fludarabine phosphate 32 Temozolomide 32 sargramostim 29 dabrafenib 27 Bevacizumab 23 fludarabine 22 Paclitaxel 21 montanide ISA 51 20 MART-1 Antigen 20 Cisplatin 19 Carboplatin 18 Sorafenib 17 Interferon-alpha 17 Granulocyte-Macrophage Colony-Stimulating Factor 17 atezolizumab 15 Radiosurgery 15 Introns 15 Blood Specimen Collection 15 cobimetinib 14 Filgrastim 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02310451 2023-09-08

EXOSOMES

Centre Hospitalier Universitaire de Nice

Phase NA Completed

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡